53 participants
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-20
- Start Date:
- 2015-12-04
- Completion:
- 2028-06-16
Conditions
- Melanoma
Interventions
- BIOLOGICAL
- DRUG
No Results Yet